AusPAR: Omalizumab (rch)
Australian Public Assessment Report
Device/Product Name
Xolair
Active ingredients
Omalizumab (rch)
AusPAR Date
Published
Sponsor
Submission Number
PM-2013-03254-1-4
Submission Type
Major variation (extension of indications)
Decision
Approved